1099 related articles for article (PubMed ID: 25556987)
1. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
Cherniakov I; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
[TBL] [Abstract][Full Text] [Related]
2. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
[TBL] [Abstract][Full Text] [Related]
3. Potentials and challenges in self-nanoemulsifying drug delivery systems.
Khan AW; Kotta S; Ansari SH; Sharma RK; Ali J
Expert Opin Drug Deliv; 2012 Oct; 9(10):1305-17. PubMed ID: 22954323
[TBL] [Abstract][Full Text] [Related]
4. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
[TBL] [Abstract][Full Text] [Related]
5. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
Kohli K; Chopra S; Dhar D; Arora S; Khar RK
Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
[TBL] [Abstract][Full Text] [Related]
6. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based formulations for oral administration of poorly water-soluble drugs.
Mu H; Holm R; Müllertz A
Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
[TBL] [Abstract][Full Text] [Related]
8. Self-emulsifying Drug Delivery System Improve Oral Bioavailability: Role of Excipients and Physico-chemical Characterization.
Zhu Y; Ye J; Zhang Q
Pharm Nanotechnol; 2020; 8(4):290-301. PubMed ID: 32781978
[TBL] [Abstract][Full Text] [Related]
9. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
10. In vitro Methods for In vitro-In vivo Correlation (IVIVC) for Poorly Water Soluble Drugs: Lipid Based Formulation Perspective.
Kazi M; Al Amri R; Alanazi FK; Hussain MD
Curr Drug Deliv; 2018; 15(7):918-929. PubMed ID: 29336263
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Insight on Recent Advancements in Self-emulsifying Drug Delivery Systems.
Kadian R; Nanda A
Curr Drug Deliv; 2023; 20(8):1095-1114. PubMed ID: 36111756
[TBL] [Abstract][Full Text] [Related]
12. Oral lipid based drug delivery system (LBDDS): formulation, characterization and application: a review.
Rahman MA; Harwansh R; Mirza MA; Hussain S; Hussain A
Curr Drug Deliv; 2011 Jul; 8(4):330-45. PubMed ID: 21453264
[TBL] [Abstract][Full Text] [Related]
13. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
14. Efavirenz Self-Nano-Emulsifying Drug Delivery System: In Vitro and In Vivo Evaluation.
Kamble RN; Mehta PP; Kumar A
AAPS PharmSciTech; 2016 Oct; 17(5):1240-7. PubMed ID: 26573159
[TBL] [Abstract][Full Text] [Related]
15. Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations.
Chudasama A; Patel V; Nivsarkar M; Vasu K; Shishoo C
Drug Deliv; 2015; 22(4):531-40. PubMed ID: 24601856
[TBL] [Abstract][Full Text] [Related]
16. Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
Chen XQ; Ziemba T; Huang C; Chang M; Xu C; Qiao JX; Wang TC; Finlay HJ; Salvati ME; Adam LP; Gudmundsson O; Hageman MJ
J Pharm Sci; 2018 May; 107(5):1352-1360. PubMed ID: 29317226
[TBL] [Abstract][Full Text] [Related]
17. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
[TBL] [Abstract][Full Text] [Related]
18. Self-Emulsifying Oral Lipid Drug Delivery Systems: Advances and Challenges.
Rani S; Rana R; Saraogi GK; Kumar V; Gupta U
AAPS PharmSciTech; 2019 Feb; 20(3):129. PubMed ID: 30815765
[TBL] [Abstract][Full Text] [Related]
19. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation.
Ramasahayam B; Eedara BB; Kandadi P; Jukanti R; Bandari S
Drug Dev Ind Pharm; 2015 May; 41(5):753-63. PubMed ID: 24641324
[TBL] [Abstract][Full Text] [Related]
20. Toxicity Study of a Self-nanoemulsifying Drug Delivery System Containing N-methyl pyrrolidone.
Agrawal AG; Kumar A; Gide PS
Drug Res (Stuttg); 2015 Aug; 65(8):446-8. PubMed ID: 25823509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
